Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2463-2472

  Yamada, Takashi ^a,b   Manos, M Michele ^c   Peto, Julian ^d   Greer, Catherine E ^e   Muñoz, Nubia ^f   Bosch, F Xavier ^g   Wheeler, Cosette M ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e NOVARTIS PHARMA AG   (Switzerland)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS CLASSIFICATION;

EID: 0031052028     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2463-2472.1997     Document Type: Article

References (36)

1. Bauer, H. M., C. E. Greer, and M. M. Manos. 1992. Determination of genital HPV infection using consensus PCR, p. 131-152. In C. S. Herrington and J. O. D. McGee (ed.), Diagnositic molecular pathology: a practical approach. Oxford University Press, Oxford, United Kingdom.
2. Bavin, P. J., P. G. Walker, and V. C. Emery. 1993. Sequence microheterogeneity in the long control region of clinical isolates of human papillomavirus type 16. J. Med. Virol. 39:267-272.
3. Bernard, H.-U., S.-Y. Chan, M. M. Manos, C.-K. Ong, L. L. Villa, H. Delius, C. L. Peyton, H. M. Bauer, and C. M. Wheeler. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170:1077-1085.
4. Bosch, F. X., M. M. Manos, N. Muñoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, and I. B. S. C. C. Study Group. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
5. Cheng, G., J. P. Icenogle, R. Kirnbauer, N. L. Hubbert, M. E. St Louis, C. Han, E. I. Svare, S. K. Kjaer, D. R. Lowy, and J. T. Schiller. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J. Infect. Dis. 172:1584-1587.
6. Conrad-Stoppler, M., K. Ching, H. Stoppler, K. Clancy, F. X. Bosch, N. Munoz, K. Shah, R. Schlegel, and J. Icenogle. 1996. Natural variants of the HPV 16 E6 protein differ in immortalizing activity and ability to degrade p53. J. Virol. 70:6987-6993.
7. Ellis, J. R. M., P. J. Keating, J. Baird, E. F. Hounsell, D. V. Renouf, M. Rowe, D. Hopkins, M. F. Duggan-Keen, J. S. Bartholomew, L. S. Young, and P. L. Stern. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1:464-470.
8. Eluf-Neto, J., M. Booth, N. Muñoz, F. X. Bosch, C. J. L. M. Meijer, and Walboomers. 1994. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer 69:114-119.
9. Eschle, D., M. Dürst, J. ter Meulen, J. Luande, H. C. Eberhardt, M. Pawlita, and L. Gissmann. 1992. Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J. Gen. Virol. 73:1829-1832.
10. Fujinaga, Y., K. Okazawa, A. Nishikawa, Y. Yamakawa, M. Fukushima, I. Kato, and K. Fujinaga. 1994. Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 9:85-92.
11. Fujinaga, Y., K. Okazawa, Y. Ohashi, Y. Yamakawa, M. Fukushima, I. Kato, and K. Fujinaga. 1990. Human papillomavirus type 16 E7 gene sequence in human cervical carcinoma analysed by polymerase chain reaction and direct sequencing. Tumor Res. 25:85-91.
12. Hecht, J. L., A. S. Kadish, G. Jiang, and R. D. Burk. 1995. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer 60:369-376.
13. Ho, L., S.-Y. Chan, R. D. Burk, B. C. Das, K. Fujinaga, J. P. Icenogle, T. Kahn, N. Kiviat, W. Lancaster, P. Mavromara-Nazos, V. Labropoulou, S. Mitrani-Rosenbaum, M. Norrild, M. R. Pillai, J. Stoerker, K. Syrjanen, S. Syrjanen, S.-K. Tay, L. L. Villa, C. M. Wheeler, A.-L. Williamson, and H.-U. Bernard. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67:6413-6423.
14. Ho, L., S.-Y. Chan, V. Chow, T. Chong, S.-K. Tay, L. L. Villa, and H.-U. Bernard. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J. Clin. Microbiol. 29:1765-1772.
15. Ho, L., S.-K. Tay, S.-Y. Chan, and H.-U. Bernard. 1993. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J. Infect. Dis. 168:803-809.
16. Icenogle, J. P., M. Laga, D. Miller, R. A. Tucker, and W. C. Reeves. 1992. Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J. Infect. Dis. 166:1210-1216.
17. Icenogle, J. P., P. Sathya, D. L. Miller, R. A. Tucker, and W. E. Rawls. 1991. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 184: 101-107.
18. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Durst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
19. Koutsky, L., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intrepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
20. Londesborough, P., L. Ho, G. Terry, J. Cuzick, C. Wheeler, and A. Singer. 1996. Human papillomavirus (HPV) genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities. Int. J. Cancer 69:364-368.
21. Matsukura, T., T. Kanda, A. Furuno, H. Yoshikawa, T. Kawana, and K. Yoshiike. 1986. Cloning of monomer human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J. Virol. 58:979-982.
22. Muñoz, N., F. X. Bosch, S. de Sanjosé, L. Tafur, I. Izarzugaza, M. Gili, P. Viladiu, C. Navarro, C. Martos, N. Ascunce, L. C. Gonzalez, J. M. Kaldor, E. Guerrero, A. Lörincz, M. Santamaria, P. Alonso de Ruiz, N. Aristizabal, and K. Shah. 1992. The causal link between human papillomavirus and cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52:743-749.
23. Muñoz, N., L. Crawford, and P. Coursaget. 1995. HPV vaccines and their potential use in the prevention and treatment of cervical neoplasia. Papillomavirus Rep. 6:54-55.
24. Myers, G., H.-U. Bernard, H. Delius, C. Baker, J. Icenogle, A. Halpern, and C. Wheeler. 1995. Human papillomavirus. A compilation of analysis of nucleic acid and amino acid sequences. Publication LA-UR 95-3675. Los Alamos National Laboratory, Los Alamos, N.M.
25. Pushko, P., T. Sasagawa, J. Cuzick, and L. Crawford. 1994. Sequence variation in the capsid protein genes of human papillomavirus type 16. J. Gen. Virol. 75:911-916.
26. Sanger, F., S. Nicklen, and A. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
27. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholer, C. K. Stanton, and M. M. Manos. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
28. Seedorf, K., G. Krämmer, M. Dürst, S. Suhai, and W. G. Röwenkamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
29. Smits, H. L., K. F. Traanberg, M. R. L. Krul, P. R. Prussia, C. L. Kuiken, M. F. Jebbink, J. A. F. W. Kleyne, R. H. van den Berg, B. Capone, A. de Bruyn, and J. ter Schegget. 1994. Identification of a unique group of human papillomavirus type 16 sequence variants among clinical isolates from Barbados. J. Gen. Virol. 75:2457-2462.
30. Stewart, A.-C. M., A. M. Eriksson, M. M. Manos, N. Muñoz, F. X. Bosch, J. Peto, and C. M. Wheeler. 1996. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol. 70:3127-3136.
31. Swofford, D. L. 1993. Phylogenetic analysis using parsimony: PAUP, version 3.1. Illinois Natural History Survey, Champaign, Ill.
32. Wheeler, C. M., A. Hildesheim, and M. Schiffman. Human papillomavirus (HPV) type 16 E6 nucleotide variations as cervical disease correlates. Submitted for publication.
33. Wheeler, C. M., T. Yamada, A. Hildesheim, and S. A. Jenison. 1997. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol. 35:11-19.
34. Xi, L. F., G. W. Demers, L. A. Koutsky, N. B. Kiviat, J. Kuypers, H. Watts, K. K. Holmes, and D. A. Galloway. 1995. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J. Infect. Dis. 172:747-755.
35. Xi, L. F., L. A. Koutsky, J. Kuypers, D. A. Galloway, J. P. Hughes, C. M. Wheeler, K. K. Holmes, and N. B. Kiviat. Risk of cervical intraepithelial neoplasia grade 2-3 in relation to human papillomavirus type 16 variants. Submitted for publication.
36. Yamada, T., C. M. Wheeler, A. L. Halpern, A.-C. M. Stewart, A. Hildesheim, and S. A. Jenison. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence ananlysis of the E6, L2, and L1 coding segments. J. Virol. 69:7743-7753.